PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript
Operator: Good morning. And welcome to PDS Biotech's call to discuss the company's Year-End 2023 Financial Results and Clinical Strategy Update Conference Call.
Pds Biotechnology Corp (PDSB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 381,411 | $1,117,534 | 0% | |
| 2. | Citadel Investment Group Ken Griffin | 48,710 | $142,720 | -6% | 0% |
| 3. | Centiva Capital Karim Abbadi And Edward Mcbride | 47,966 | $140,540 | 0% | |
| 4. | 45,000 | $131,850 | -36% | 0% | |
| 5. | Point72 Asia (Singapore) Steve Cohen | 39,349 | $115,293 | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.00 | 100 | 4,075 | 2021-12-13 | Filing | ||
| $9.00 | 100 | 3,975 | 2021-12-13 | Filing | ||
| $8.90 | 400 | 3,875 | 2021-12-13 | Filing | ||
| $9.00 | 2,500 | 3,475 | 2021-12-13 | Filing | ||
| $8.50 | 5,882 | 63,790 | 2021-06-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.41 | 2,500 | Officer, Director | 570,602 | 2018-03-22 | Filing | |
| $16.52 | 2,500 | Officer, Director | 573,102 | 2018-03-21 | Filing | |
| $16.47 | 5,000 | Officer, Director | 575,602 | 2018-03-20 | Filing | |
| $16.66 | 2,500 | Officer, Director | 580,602 | 2018-03-19 | Filing | |
| $15.08 | 2,500 | Officer, Director | 70,236 | 2018-03-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,881,438 | $9,350,746 | 0% | |
| 2. | 1,505,671 | $7,483,185 | 0% | |
| 3. | 633,204 | $3,147,385 | 0% | |
| 4. | 552,032 | $2,743,599 | 0% | |
| 5. | 336,594 | $1,733,459 | 0.31% |
News See All
PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript
Operator: Good morning. And welcome to PDS Biotech's call to discuss the company's Year-End 2023 Financial Results and Clinical Strategy Update Conference Call.
PDS Biotechnology Corporation (NASDAQ:PDSB) Q3 2023 Earnings Call Transcript
Operator: Greetings and welcome to the PDS Biotechnology Third Quarter 2023 Earnings Call and Webcast. At this time, all participants are in a listen-only mode. [Operator Instructions].
PDS Biotechnology Corporation (NASDAQ:PDSB) Q2 2023 Earnings Call Transcript
Operator: Hello and welcome to the PDS Biotechnology Second Quarter 2023 Earnings Call and Webcast. If anyone should require Operator assistance, please press star, zero on your telephone keypad.
PDS Biotechnology Corporation (NASDAQ:PDSB) Q1 2023 Earnings Call Transcript
Operator: Hello, and welcome to the PDS Biotechnology First Quarter 2023 Earnings Conference Call and Webcast.
PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2022 Earnings Call Transcript
Operator: Greetings. Welcome to PDS Biotechnology Fourth Quarter 2022 and Full-Year Earnings Conference Call. . A question-and-answer session will follow the formal presentation.
12 Best Biotech Stocks to Buy Under $10
The past two years have been challenging for the biotech sector, based on the market performance of biotech equities. Compared to larger stock market indexes, biotechnology indices underperformed.
11 Popular Penny Stocks On Robinhood
There are various reasons why an investor might want to invest in penny stocks.
Is PDS Biotechnology Corporation (PDSB) A Good Stock To Buy?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Where Do Hedge Funds Stand On PDS Biotechnology Corporation (PDSB)?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
Billionaire Hedge Funds
